These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 35369354)
21. Cardiotoxicity evaluation using magnetic resonance imaging in breast Cancer patients (CareBest): study protocol for a prospective trial. Hong YJ; Kim GM; Han K; Kim PK; Lee SA; An E; Lee JY; Lee HJ; Hur J; Kim YJ; Kim MJ; Choi BW BMC Cardiovasc Disord; 2020 Jun; 20(1):264. PubMed ID: 32493217 [TBL] [Abstract][Full Text] [Related]
22. Radiotherapy-Induced Cardiotoxicity: The Role of Multimodality Cardiovascular Imaging. Podlesnikar T; Berlot B; Dolenc J; Goričar K; Marinko T Front Cardiovasc Med; 2022; 9():887705. PubMed ID: 35966531 [TBL] [Abstract][Full Text] [Related]
24. Assessment of early anthracycline-induced cardiotoxicity and liver injury with T2 and T2* mapping in rabbit models. Feng XL; Qi WY; Xiao ZY; Zheng X; Zhang XY; Liu T; Kou XY; Chen J Eur Radiol; 2024 Jan; 34(1):226-235. PubMed ID: 37552260 [TBL] [Abstract][Full Text] [Related]
25. Anthracycline-Induced Cardiomyopathy in Cancer Survivors: Management and Long-Term Implications. Mohsenizadeh SA; Rajaeinejad M; Khoshfetrat M; Arefizadeh R; Mousavi SH; Mosaed R; Kazemi-Galougahi MH; Jalaeikhoo H; Faridfar A; Nikandish M; Alavi-Moghadam S; Arjmand B Adv Exp Med Biol; 2024 Jun; ():. PubMed ID: 38842787 [TBL] [Abstract][Full Text] [Related]
26. Benefits of antihypertensive medications for anthracycline- and trastuzumab-induced cardiotoxicity in patients with breast cancer: Insights from recent clinical trials. Rygiel K Indian J Pharmacol; 2016; 48(5):490-497. PubMed ID: 27721532 [TBL] [Abstract][Full Text] [Related]
27. Update in imaging of cancer therapy-related cardiac toxicity in adults. de Baat EC; Naaktgeboren WR; Leiner T; Teske AJ; Habets J; Grotenhuis HB Open Heart; 2021 Apr; 8(1):. PubMed ID: 33863836 [TBL] [Abstract][Full Text] [Related]
28. Multimodality Cardiovascular Imaging of Cardiotoxicity Due to Cancer Therapy. Contaldi C; Montesarchio V; Catapano D; Falco L; Caputo F; D'Aniello C; Masarone D; Pacileo G Life (Basel); 2023 Oct; 13(10):. PubMed ID: 37895484 [TBL] [Abstract][Full Text] [Related]
29. Assessment of Native Myocardial T1 Mapping for Early Detection of Anthracycline-Induced Cardiotoxicity in Patients with Cancer: a Systematic Review and Meta-analysis. Mohamed AA; Elmancy LY; Abulola SM; Al-Qattan SA; Mohamed Ibrahim MI; Maayah ZH Cardiovasc Toxicol; 2024 Jun; 24(6):563-575. PubMed ID: 38700665 [TBL] [Abstract][Full Text] [Related]
30. Cardiac imaging techniques for the assessment of immune checkpoint inhibitor-induced cardiotoxicity and their potential clinical applications. Li Y; Liu PJ; Zhang ZL; Wang YN Am J Cancer Res; 2022; 12(8):3548-3560. PubMed ID: 36119829 [TBL] [Abstract][Full Text] [Related]
32. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2010; 10(16):1-80. PubMed ID: 23074393 [TBL] [Abstract][Full Text] [Related]
33. Cardiovascular magnetic resonance characterization of myocardial tissue injury in a miniature swine model of cancer therapy-related cardiovascular toxicity. Nakata K; Kucukseymen S; Cai X; Yankama T; Rodriguez J; Sai E; Pierce P; Ngo L; Nakamori S; Tung N; Manning WJ; Nezafat R J Cardiovasc Magn Reson; 2024 Summer; 26(1):101033. PubMed ID: 38460840 [TBL] [Abstract][Full Text] [Related]
34. Potential usefulness of diastolic parameters measured by strain imaging echocardiography in the early prediction of chemotherapy-induced cardiotoxicity. Hernandez-Suarez DF; López-Candales A Med Hypotheses; 2017 Apr; 101():30-32. PubMed ID: 28351486 [TBL] [Abstract][Full Text] [Related]
35. Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention. Pai VB; Nahata MC Drug Saf; 2000 Apr; 22(4):263-302. PubMed ID: 10789823 [TBL] [Abstract][Full Text] [Related]
36. Assessment and Management of Cardiotoxicity in Hematologic Malignancies. Bojan A; Torok-Vistai T; Parvu A Dis Markers; 2021; 2021():6616265. PubMed ID: 33613788 [TBL] [Abstract][Full Text] [Related]
37. Current and emerging modalities for detection of cardiotoxicity in cardio-oncology. Khouri MG; Klein MR; Velazquez EJ; Jones LW Future Cardiol; 2015 Jul; 11(4):471-84. PubMed ID: 26235924 [TBL] [Abstract][Full Text] [Related]
38. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392 [TBL] [Abstract][Full Text] [Related]
39. Cardiovascular Magnetic Resonance Imaging in the Early Detection of Cardiotoxicity Induced by Cancer Therapies. Wei X; Lin L; Zhang G; Zhou X Diagnostics (Basel); 2022 Jul; 12(8):. PubMed ID: 36010197 [TBL] [Abstract][Full Text] [Related]
40. Cardiotoxicity of Biological Therapies in Cancer Patients: An In-depth Review. Madanat L; Gupta R; Weber P; Kumar N; Chandra R; Ahaneku H; Bansal Y; Anderson J; Bilolikar A; Jaiyesimi I Curr Cardiol Rev; 2023; 19(3):e310522205428. PubMed ID: 35642110 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]